Abnormal levels of these substances can indicate an increased risk of conditions such as Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), neural tube defects (such as spina bifida), or other chromosomal abnormalities.

The results of the Quadruple Test, along with other factors such as maternal age and gestational age, are used to calculate the risk of these conditions. If the risk is deemed to be high, further diagnostic testing such as chorionic villus sampling (CVS) or amniocentesis may be recommended for a definitive diagnosis.

It’s important to note that the Quadruple Test is a screening test, not a diagnostic test, and it cannot provide a definitive diagnosis of fetal abnormalities. However, it helps identify pregnancies at increased risk, allowing for appropriate counseling and consideration of further testing options.

Overall, the Maternal Screen Quadruple Test serves as a valuable tool in prenatal care, providing important information to expectant parents and healthcare providers to guide decision-making and pregnancy management.